Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Exploratory, Non-randomised, Non-controlled, Prospective, Open-label Phase II Study Evaluating Safety and Efficacy of IBU, G-CSF and Plerixafor as Stem Cell Mobilization Regimen in Patients Affected by X-CGD

NCT03055247 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT03055247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03055247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Exploratory, Non-randomised, Non-controlled, Prospective, Open-label Phase II Study Evaluating Safety and Efficacy of IBU, G-CSF and Plerixafor as Stem Cell Mobilization Regimen in Patients Affected by X-CGD
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Recruiting
Start date
November 6, 2015
Completion date
July 18, 2026
Enrollment
3 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic granulomatous disease x-linked (x-cgd)